NCT03084523View on ClinicalTrials.gov

Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRI

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 26, 2017

Primary Completion Date

June 3, 2024

Study Completion Date

June 3, 2024

Conditions
StrokeIntracranial Atherosclerosis
Interventions
DRUG

Ferumoxytol Injectable Product

Patients will be administered a single dose of ferumoxytol as an MRI contrast

Trial Locations (1)

06510

Yale University, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT03084523 - Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRI | Biotech Hunter | Biotech Hunter